002393.SZ
力生制药
SZSE · Healthcare · C 制造业 · CN
CNY 13.82
−4.16%Aug 20, 2026, 08:33 UTC
Lisheng Pharmaceutical announced its first-half 2026 results: revenue of 642 million yuan, down 12.29% year-on-year; net profit attributable to shareholders of 78.326 million yuan, down 77.16% year-on-year.
Source: